DIRS.INFO The most relevant business & tech news

☆ This fund manager beating the market is betting AI stocks like Micron will outperform again in second half
▼ + stars: | 2024-07-03 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +3 min

The second half of the year is underway, and investor Andrew Graham thinks technology stocks will continue to lead the market higher. Investors have debated whether technology stocks can sustain their lofty gains, or if the market rally is due to broaden. The investor likes semiconductor names such as Nvidia and Micron , which he said should benefit from the ongoing memory cycle. MU YTD mountain MU year to date Outside of tech, Graham favors industrials, which are adjacent to the AI theme. The portfolio manager also has positions in NextEra Energy , which he thinks is primed to capitalize on AI.

Persons: Andrew Graham, Graham, —, industrials, that's, Eli Lilly, Capital's Organizations: Nvidia, Investors, Jackson, Capital, CNBC, Micron, MU, Arista, Dell, Arm Holdings, Broadcom, NextEra Energy Locations: Eaton, Graham, U.S

☆ Wall Street firm gets it right with Best Buy call, plus Eli Lilly shares move up
▼ + stars: | 2024-07-03 | by ( Morgan Chittum | ) www.cnbc.com time to read: +2 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Davidson analysts touted Best Buy stock on Wednesday, listing artificial-intelligence-enabled PCs as a positive catalyst for the electronics retailer. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Eli Lilly, Jeff Marks, Davidson, Jim Cramer's, Jim Organizations: CNBC, Nasdaq, New York Stock Exchange, Independence, Food and Drug Administration, Jefferies Locations: U.S, D.A

☆ Stocks making the biggest moves premarket: Paramount, Tesla, Constellation Brands and more
▼ + stars: | 2024-07-03 | by ( Samantha Subin | ) www.cnbc.com time to read: +2 min

Tesla — The electric vehicle maker rose nearly 3% , a day after posting stronger-than-expected delivery numbers for the second quarter. Shares popped 10% during Tuesday's session. Constellation Brands — The beer and wine stock rose more than 2% after a better-than-expected earnings report. Southwest Airlines — Shares were fractionally lower after the airline carrier announced it had adopted a shareholder rights plan. Shares dipped about 1% during Tuesday's session.

Persons: Tesla, LSEG, Eli Lilly, — CNBC's Lisa Han, Jesse Pound, Sarah Min Organizations: Paramount, Paramount Global, Skydance Media, The New York Times, Wall Street Journal, Constellation Brands, Constellation, Southwest Airlines —, Elliott Investment Management, Food and Drug Administration, MGM Resorts, MGM Resorts International

☆ FDA approves a new Alzheimer's drug from Eli Lilly
▼ + stars: | 2024-07-03 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFDA approves a new Alzheimer's drug from Eli LillyEvan Seigerman, BMO Capital Markets senior research analyst, joins 'Squawk Box' to discuss the FDA's approval of Eli Lilly's Alzheimer's drug donanemab, how much revenue it could add to Elil LIlly's bottom line, and the details behind the newly approved drug.

Persons: Eli Lilly Evan Seigerman, Eli Lilly's Organizations: FDA, BMO Capital Markets

☆ 10 things to watch in the stock market Wednesday after the S&P 500's record close
▼ + stars: | 2024-07-03 | by ( Jeff Marks | ) www.cnbc.com time to read: +5 min

Pepsico 's price target was lowered to $190 from $200 at Cowen, which cited some weakness in salty snacks. Loops Capital raised its price target for off-price retailer TJX to $125 from $115. Lululemon 's price target was lowered to $470 from $505 at Baird, but kept its outperform rating. Pepsico 's price target was lowered to $190 from $200 at Cowen, which cited some weakness in salty snacks. Lululemon 's price target was lowered to $470 from $505 at Baird, but kept its outperform rating.

Persons: Tuesday's, depletions, Jefferies, Eli Lilly, Lululemon, Baird, BTIG, Dell, Amphenol, Jim Cramer's, Jim Cramer, Jim, John Thys Organizations: Constellation Brands, Pepsico, Cowen, Nike, MGM Resorts, Bank of America's, Jim Cramer's Charitable, CNBC, AFP, Getty Locations: Zeebrugge, Belgium

☆ FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
▼ + stars: | 2024-07-02 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. The Food and Drug Administration on Tuesday approved Eli Lilly 's Alzheimer's drug donanemab, expanding the limited treatment options for the mind-wasting disease in the U.S. The agency approved the treatment, which will be sold under the brand name Kisunla, for adults with early symptomatic Alzheimer's disease, according to the company. "Having multiple treatment options is the kind of advancement we've all been waiting for — all of us who have been touched, even blindsided, by this difficult and devastating disease." It's a long-awaited win for Eli Lilly after donanemab faced obstacles in its path to market.

Persons: Eli Lilly, Joanne Pike, donanemab Organizations: Company, The, Drug Administration, U.S, Alzheimer's Association, FDA Locations: Indianapolis , Indiana, U.S

☆ Microsoft and Eli Lilly are among the most overbought stocks as the first half ends
▼ + stars: | 2024-06-28 | by ( Brian Evans | ) www.cnbc.com time to read: +3 min

Shares of Microsoft registered a 14-day RSI reading of 74. MSFT YTD mountain MSFT YTD Shares of Eli Lilly are also overbought, with a 14-day RSI of 83, putting the drug manufacturer at the top of the list. FedEx is also overbought, with a 14-day RSI of 77. Among the oversold names, Walgreens Boots Alliance and Waters Corporation top the list with a 14-day RSI reading of 20, followed by Pool Corp . with an RSI reading of 22.

Persons: Friday's, Wall, Eli Lilly, Eli Lilly's Organizations: Dow Jones, Nasdaq, Nvidia, Microsoft, CNBC Pro, Union, FedEx, Walgreens Boots Alliance, Waters Corporation, Pool Corp, Walgreens

Here's a rapid-fire update on all 33 stocks in Jim Cramer's Charitable Trust, the portfolio we use for the CNBC Investing Club. Best Buy : Jim said Best Buy's pullback in recent days has created a buying opportunity in the electronics retailer. Salesforce : The stock has in recent weeks clawed back some of its post-earnings plunge , even before Thursday's 6% surge. Wynn Resorts : Wynn is another stock in the portfolio that, it's become increasingly clear, trades based on its exposure to China. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Jim Cramer's, Jim, Wall, Abbott, Johnson, We're, haven't, it's, Walt Disney, Estee Lauder, levered, Eli Lilly, Lilly, Morgan Stanley, Goldman Sachs, OpenAI, Jensen Huang, Nikesh Arora's, Stanley Black, Decker, TJX, We've, Wells, Charlie Scharf poaches, Wynn, Jim Cramer, Michael M Organizations: Jim Cramer's Charitable Trust, CNBC, Club, Apple, Abbott Laboratories, Prime, Web, Broadcom, VMWare, Costco Wholesale, Costco, Coterra Energy, DuPont, Walt, Disney, Nvidia, Ford Motor, Ford, Blue, Motors, GE Healthcare, GE, Management, Honeywell, Linde, Microsoft, Palo Alto Networks, Procter & Gamble, Constellation Brands, Modelo, Corona, Fed, TJX, JPMorgan, Wynn Resorts, Wynn, Jim Cramer's Charitable, Traders, New York Stock Exchange, Santiago, Getty Locations: China, Covid, Dover, Eaton, Palo Alto, U.S, Wells Fargo, Las Vegas

☆ These are the most expensive S&P 500 stocks heading into the second half
▼ + stars: | 2024-06-27 | by ( Brian Evans | ) www.cnbc.com time to read: +4 min

Artificial Intelligence plays Top AI plays were among the list of expensive stocks in the S & P 500, including Broadcom , Lam Research , Intel and Super Micro Computer . Each stock's price-earnings ratio equates to a roughly 60% to 66% premium over the historical average. SMCI YTD mountain Super Micro Computer stock. Super Micro Computer, meanwhile, has continued to ride the AI wave despite some weakness last month after third-quarter revenue missed analyst expectations. The stock's trailing 12-month price-earnings ratio is also more than double its five-year average, at a 63% premium.

Persons: Elon Musk, Daron Acemoglu, Goldman Sachs, Eli Lilly Eli Lilly, Eli Lilly, Biogen's Leqembi Organizations: CNBC Pro, Nvidia, CNBC, Stock, Artificial Intelligence, Broadcom, Lam Research, Intel, Micro, Super Micro Computer, Computer, Wall, Bank of America, Micro Computer, Dell, Massachusetts Institute of Technology, U.S . Food, Drug Administration Locations: U.S

☆ Eli Lilly and Novo Nordisk are ahead in manufacturing but need time to meet demand, says Louise Chen
▼ + stars: | 2024-06-27 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailEli Lilly and Novo Nordisk are ahead in manufacturing but need time to meet demand, says Louise ChenLouise Chen, Cantor Fitzgerald analyst, joins CNBC's 'Squawk Box' to discuss Eli Lilly's surge over the past year, manufacturing, and more.

Persons: Eli Lilly, Louise Chen Louise Chen, Cantor Fitzgerald, Eli Lilly's Organizations: Novo Nordisk

The iShares U.S. Pharmaceuticals ETF (IHE) is up 9% since July 2015, when it hit a fresh all-time high. All of the back-and-forth movement since 2015 has produced what could be a monstrous bullish pattern. But we're trying to capture a major breakout from an area that's done next to nothing in nearly a decade. INVA, on the other hand, bottomed in March 2023, and just recently broke out of a large inverse head & shoulders pattern. BEFORE MAKING ANY FINANCIAL DECISIONS, YOU SHOULD STRONGLY CONSIDER SEEKING ADVICE FROM YOUR OWN FINANCIAL OR INVESTMENT ADVISOR.

Persons: IHE, Eli Lilly, Johnson, JNJ, MRK, Frank Cappelleri Organizations: U.S . Pharmaceuticals, IHE, Merck, CNBC, NBC UNIVERSAL Locations: U.S, LLY

☆ DuPont draws suitors for its water unit, plus what's driving Eli Lilly's bounce
▼ + stars: | 2024-06-25 | by ( Morgan Chittum | ) www.cnbc.com time to read: +3 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Jim Cramer argued that the market's been too focused on the AI darling. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Jim, Eli Lilly, Novo Nordisk's Wegovy, Mounjaro, Ozempic, Jim Cramer's Organizations: CNBC, Nasdaq, Nvidia, DuPont, Bloomberg, Novo Nordisk's, Club Locations: China, LLY

☆ Jim Cramer's top picks for pet-centric stocks
▼ + stars: | 2024-06-25 | by ( Julie Coleman | ) www.cnbc.com time to read: +2 min

As some of the market's hottest stocks take a pause, CNBC's Jim Cramer on Tuesday told investors it may be wise to get into some "slowdown stocks," like companies with products related to pets. Cramer suggested the "post-Covid drought" in these stocks could be over and pinpointed three: online retailer Chewy , animal health care company Elanco and J.M. Smucker, which owns pet food brands alongside its namesake jelly products and snacks for people. Smucker's efforts to trim down its pet food portfolio. "I'm going with Smucker because of its distinctive shrink-to-grow-more-profitably lucrative narrative in pet food," he said.

Persons: Jim Cramer, Cramer, Eli Lilly, Elanco, J.M, Smucker

☆ Novo Nordisk's Wegovy weight loss drug approved in China
▼ + stars: | 2024-06-25 | by ( Karen Gilchrist | ) www.cnbc.com time to read: +2 min

Novo Nordisk said Tuesday that its Wegovy weight loss treatment has been approved in China for long-term weight management, opening up the blockbuster drug for sale in the world's second largest economy. China's National Medical Products Administration "recently" approved the weekly injectable drug, Novo Nordisk said in a press release on the Chinese version of its website, according to Google translate. Novo Nordisk did not immediately respond to CNBC's request for further information on the proposed pricing and rollout timeline of the drugs. The company's Ozempic diabetes drug was approved in 2021 and saw sales in the greater China region double last year. On Monday, Novo Nordisk announced it is investing $4.1 billion to expand its manufacturing in the U.S.

Persons: —, Eli Lilly Organizations: Novo Nordisk, Medical Products Administration, Google, Reuters, National Health Commission, U.S Locations: China, Danish, London, Clayton , North Carolina

☆ Stocks making the biggest moves before the bell: Nvidia, Ferrari, Planet Fitness, Cinemark and more
▼ + stars: | 2024-06-24 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

UPS shares were unchanged in premarket trading. Planet Fitness — The budget-friendly gym chain climbed 3.1% after TD Cowen named the stock a top pick and raised its rating to buy from hold. Affirm — The buy-now-pay-later stock jumped 3.2% on the heels of Goldman Sachs' initiation at a buy rating. IBM — The legacy tech giant moved 1.4% higher after Goldman Sachs initiated coverage with a buy rating. Cinemark — Shares popped 3.3% after Roth MKM upgraded the American movie theater chain to buy from neutral, citing "meaningful box office improvement."

Persons: Eli Lilly — ResMed, Eli Lilly's, Eli Lilly, Jefferies, TD Cowen, Goldman Sachs, Goldman, Roth MKM, —, Michelle Fox, Sarah Min, Jesse Pound Organizations: Coyote Logistics, UPS, RXO, Coyote, Nvidia, Carrier, Citi, Ferrari —, UBS, Anheuser, Busch InBev —, IBM

☆ Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
▼ + stars: | 2024-06-24 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy, diabetes treatment Ozempic and other injectable therapies. The company said it plans to invest $6.8 billion in production this year, up from roughly $4 billion last year. Construction of the 1.4 million-square-foot facility has begun and is expected to be completed between 2027 and 2029, Novo Nordisk said. Twelve other production sites are located in Denmark, France, China, Japan, Algeria, Brazil, Iran and Russia, according to a Novo Nordisk spokesperson. Around 35,000 U.S. patients on average start Wegovy each week today, up from roughly 27,000 in May, a Novo Nordisk spokesperson said in a statement.

Persons: Doug Langa, Clayton —, Langa, Eli Lilly Organizations: Novo Nordisk, Danish, Novo Nordisk's, Drug Administration Locations: Clayton , North Carolina, U.S, Novo, North Carolina, Clayton, Durham , North Carolina, West Lebanon , New Hampshire, Denmark, France, China, Japan, Algeria, Brazil, Iran, Russia

☆ Eli Lilly's treatment for obesity and diabetes looks promising for another severe condition
▼ + stars: | 2024-06-24 | by ( Morgan Chittum | ) www.cnbc.com time to read: +2 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. "This is what the bears should be most worried about, which is the [market] broadening out," Jim Cramer said Monday. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Morgan Stanley, Wells Fargo, Eli Lilly, Jim, Jim Cramer's Organizations: CNBC, Dow, Nasdaq, Honeywell, Coterra Energy, Nvidia, Microsoft, U.S

☆ Here are Monday's biggest analyst calls: Nvidia, Amazon, IBM, Micron, Apple, Tesla, Broadcom, Planet Fitness, UnitedHealth & more
▼ + stars: | 2024-06-24 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Morgan Stanley initiates Ryder System as overweight Morgan Stanley said the transformation is underway for the transport company. " Morgan Stanley names UnitedHealth a top pick Morgan Stanley said the health-care company is compelling. "With this note, we are adjusting our Top Pick to UNH (from CI), where its relative share price performance presents an opportunity in our view." Morgan Stanley initiates Elevance Health as overweight Morgan Stanley called out Elevance Health's earnings power as it initiated coverage of the stock. " Melius reiterates Apple as buy Melius raised its price target on Apple to $260 per share from $227.

Persons: Jefferies, kingmaker, CARR, Goldman Sachs, Goldman, Morgan Stanley, Ryder, UnitedHealth, Bernstein, Tesla, TD Cowen, TD, it's, Melius, BEV, Eli Lilly, LLY Organizations: Nvidia, Citi, Micron, Carrier, UBS, Anheuser, Busch InBev, IBM, Bank of America, Broadcom, VMWare, CI, Elevance Health, Cherniere Energy, Cheniere Energy Inc, Ally, Barclays, Apple, " Bank of America, Alexa, Reuters, China, JPMorgan, Royal Locations: LLY, Royal Caribbean

☆ Corona brewer Constellation is set to grab more prime real estate at stores — driving sales and its stock
▼ + stars: | 2024-06-24 | by ( Paulina Likos | ) www.cnbc.com time to read: +5 min

Constellation Brands has an upper hand in a battle for coveted — but shrinking — territory in stores, according to new Wall Street research. In fact, displays provide more of a lift to sales than shelf-space gains for brands, Jefferies analysts said. STZ 5Y mountain Constellation Brands' stock performance over the past five years. We have a buy-it-here 1 rating on Constellation Brands and a price target of $300, implying about 14% upside from Friday's close. Constellation Brands' Corona Light is displayed for sale at a grocery store in New York.

Persons: Jefferies, Molson Coors, we've, —, Jim Cramer, Eli Lilly, Jim, Elliott, Jim Cramer's, Scott Eells Organizations: Constellation Brands, Modelo, Pacifico, Jefferies, Anheuser, Busch InBev, Molson, Boston Beer, Club, Investing Club, Elliott Management, CNBC, Bloomberg, Getty Locations: Corona, Victoria, U.S, New York

☆ Stocks making the biggest moves midday: ResMed, Affirm, Nvidia, Anheuser-Busch and more
▼ + stars: | 2024-06-24 | by ( Michelle Fox | ) www.cnbc.com time to read: +4 min

Affirm — The buy now, pay later stock popped 10% after Goldman Sachs assumed coverage of the name at a buy rating. Roth MKM upgraded Cinemark to a buy from a neutral rating, saying that headwinds should soon shift to "very attractive tailwinds." Anheuser-Busch InBev — The brewing company's shares rose around 3% after UBS upgraded the stock to buy from neutral. Carrier Global — The heating and ventilation stock rose 3% on the heels of a Citi upgrade to buy from neutral. Energy stocks – A slate of energy names rose as crude oil futures jumped to start the last week of June.

Persons: Eli Lilly, tirzepatide, Eli Lilly's, ATTR, Goldman Sachs, Will Nance, Roth MKM, headwinds, Morgan Stanley, Cowen, Ferrari, Brent, SLB, Baker Hughes, — CNBC's Lisa Han, Jesse Pound, Alex Harring, Sean Conlon, Samantha Subin Organizations: Systems, Food and Drug Administration, Coyote Logistics, UPS, Alnylam Pharmaceuticals, Nvidia, Microsoft, Anheuser, Busch InBev, UBS, Busch, IBM, Ryder, Carrier, Citi, Ferrari —, Energy, West Texas Intermediate, APA Locations: U.S

☆ Three-Stock Lunch: Nvidia, Eli Lilly & Chipotle
▼ + stars: | 2024-06-21 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThree-Stock Lunch: Nvidia, Eli Lilly & ChipotleDavid Bahnsen, chief investment officer at the Bahnsen Group, joins 'Power Lunch' to discuss stock plays for three stocks, including Nvidia, Eli Lilly, and Chipotle.

Persons: Eli Lilly, Chipotle David Bahnsen Organizations: Nvidia, Bahnsen

☆ Here's our first-quarter earnings report card for 32 stocks in the portfolio
▼ + stars: | 2024-06-21 | by ( Zev Fima | ) www.cnbc.com time to read: +14 min

Most of the earnings reports — 25 out of 32 portfolio names — were ranked as good or great by the Investing Club. Similar to prior quarters, we grouped company results into one of four categories. Meta Platforms : Sales, earnings and cash flow results all topped expectations . However, sales and earnings both outpaced expectations, as did return on tangible common equity, a key consideration when valuing banks. The company also raised its outlook for full-year earnings growth to 25% year-over-year from 20%.

Persons: we're, Dover, Eli Lilly, Blackwell, Abbott, —, Wall, We'll, Morgan Stanley, Nikesh, Stanley Black, Wells, Estee Lauder, Fabrizio Freda, Jim Cramer's, Jim Cramer, Jim, Hock Tan, Broadcom Lucas Jackson Organizations: Investing, Apple, Services, Broadcom, VMware, Coterra, DuPont, Microsoft, Nvidia, Wynn Resorts, Super, Abbott Labs, Web Services, Constellation Brands, Constellation, Ford, Ford Pro, Wall Street, Alto Networks, Procter & Gamble, TJX, GE Healthcare, Honeywell, Linde, Jim Cramer's Charitable, CNBC Locations: Dover, China, Eaton, Las Vegas, China's Macao, billings, Wells Fargo, —

☆ Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
▼ + stars: | 2024-06-21 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +5 min

Eli Lilly presented the new data from the trials at the American Diabetes Association's 84th Scientific Sessions in Orlando, Florida, on Friday. An estimated 80 million patients in the U.S. experience the disease, Eli Lilly said in a press release. Disease resolution for OSA is defined as a patient having fewer than five AHI events per hour, according to Eli Lilly. Eli Lilly on Friday reiterated that Zepbound met the main goal of the trial, which was reducing AHI events. Eli Lilly previously announced that the FDA granted Zepbound "fast track designation" for patients with moderate-to-severe OSA and obesity.

Persons: Eli Lilly, Zepbound, Patrik Jonsson, Jonsson, Leonard Glass, —, Eli Lilly's Organizations: Food and Drug Administration, Diabetes, CNBC, OSA, FDA Locations: Orlando , Florida, U.S

☆ CNBC Daily Open: Russia-North Korea defense pact
▼ + stars: | 2024-06-20 | by ( Abid Ali | ) www.cnbc.com time to read: +3 min

This report is from today's CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Russia-North Korea partnershipRussia and North Korea signed a "comprehensive strategic partnership" deal on Wednesday, including a mutual defense pact, during President Vladimir Putin's first state visit to North Korea in 24 years. While the 2% inflation mark is significant, it was anticipated and mainly driven by lower energy prices. Musk clarifies remarksElon Musk attempted to clarify his controversial remarks after advertisers threatened to leave X. Musk previously told advertisers to "go f--- yourself."

Persons: Vladimir Putin's, Putin, Kim Jong Un, CNBC's Holly Ellyatt, Elon Musk, Musk, Eli Lilly Organizations: CNBC, Bank of England, Cannes Lions, CAC, Nasdaq Locations: Russia, North Korea, Ukraine, Cannes, France

☆ 10 things to watch in the stock market Thursday including the latest call on Nvidia
▼ + stars: | 2024-06-20 | by ( Jeff Marks | ) www.cnbc.com time to read: +4 min

Stifel raised its price target on Nvidia to $165 a share from $114, implying nearly 22% upside from Tuesday's close. Keybanc raised its price target on Club holding Meta Platforms to $540 a share from $475, citing a "meaningful uptick" in ad prices. Tesla price target lowered to $227 a share from $293 at RBC Capital, but analysts maintained their outperform rating on the electric vehicle maker's stock. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Stifel, Olive Garden, Piper Sandler, Keefe, Eli Lilly, Tesla, Uber, Jim Cramer's, Jim Cramer, Jim Organizations: Nasdaq, Nvidia, Microsoft, Darden, LongHorn, Honeywell, CAES, Holdings, Accenture, Citigroup, Citi Services, Citi . Club, RBC Capital, RBC, Jim Cramer's Charitable, CNBC Locations: U.S

Search resuls for: "Eli Lilly"

25 mentions found